FDA clears 1st fecal transplant treatment for gut infection
WASHINGTON — U.S. officials have approved the first pharmaceutical-grade version of the…
Moderna, Biogen rise; Oatly, Dentsply fall
Stocks that traded heavily or had substantial price changes Monday: Moderna, Biogen rise; Oatly…
Twitter Blue signups unavailable after raft of fake accounts
Twitter’s relaunched premium service — which grants blue-check “verification” labels to…
Biogen tabs veteran pharma leader Viehbacher as next CEO
Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug…
BioNTech earnings drop but forecast for vaccine income grows
BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that…
Moderna misses on 3Q, shaves 2022 vaccine expectations
Sliding COVID-19 vaccine sales and rising expenses for Moderna combined to produce a third quarter…
Pfizer rides Paxlovid sales to better-than-expected quarter
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales…
Strong RSV vaccine data lifts hopes after years of futility
New research shows vaccinating pregnant women helped protect their newborns from the common but…
Drugmaker Merck tops 3Q forecasts as Keytruda sales jump 20%
Merck turned in a better-than-expected third quarter and raised its 2022 forecast as the…